Search

Your search keyword '"Bhatt, Deepak"' showing total 10,427 results

Search Constraints

Start Over You searched for: Author "Bhatt, Deepak" Remove constraint Author: "Bhatt, Deepak"
10,427 results on '"Bhatt, Deepak"'

Search Results

1. Atherosclerosis evaluation and cardiovascular risk estimation using coronary computed tomography angiography.

2. Practical Bias Mitigation through Proxy Sensitive Attribute Label Generation

3. GroupMixNorm Layer for Learning Fair Models

4. Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests.

5. GRACE scores or high-sensitivity troponin for timing of coronary angiography in non-ST-elevation acute coronary syndromes

6. Early versus delayed coronary angiography in patients with out-of-hospital cardiac arrest and no ST-segment elevation: a systematic review and meta-analysis of randomized controlled trials

7. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

9. Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic Stroke.

10. Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCT

14. The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective

15. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

18. Contributors

19. Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking

20. Assessing Heuristic Bias During Care for Patients Hospitalized for Heart Failure: Get With The Guidelines-Heart Failure.

21. Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATE.

22. Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues

23. Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance

24. Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India

25. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

30. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.

31. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention

32. The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl

33. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease

34. Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

38. Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review

42. Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction

43. Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

44. Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart Failure

47. Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI

49. Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma

Catalog

Books, media, physical & digital resources